KabraDrugs 524322 full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

• Tips
• NEWS
• Tomorrow
• Forecast
• Targets
• ExpertsView
• Analysis
• Munafa AI prediction

• Forcast & Targets 524322
• 524322 Experts view
• Tomorrow's Movement 524322
• Technical Analysis Reports
• All in One Charts
• All indicators in One Charts
• 524322 History
• Money flow charts
• Weekly charts
• Monthly charts
• Moving averages charts
• MACD charts
• Force Index charts
• Stochastics charts
• PVM charts
• RSI and MRSI charts
• Renko charts
• Point and Figure charts

Daily Price and Volume

Weekly Price and Volume

Monthly Price and Volume

Yearly Price and Volume

Indicator Analysis of KabraDrugs

Tomorrow's movement Prediction of Kabra Drugs 524322 appears to be in downtrend.

And this trend seems to be continuing further.

Price is below an important level of 24.96 on charts, and if price remains below this level, then stock might show a fall in short term.

Tomorrow's movement Prediction of Kabra Drugs 524322 made a major fall in previous days. This happens when sentiment changes towards negative. This fall might deepen in coming days.

Munafa value: 25 as on Fri 22 May 2026

This Munafa value indicates that the stock is moving downwards and might continue to move down.

SMA20 is at 26 and price is deviating by 1 points

Upper Bollinger band is at 27 and lower is at 24, while middle bands are at 25 and 27

Price is coming down

Price is below 20day SMA

Price is in lower range of bands

Price action analysis of KabraDrugs (524322) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

ADX buy sell signal for KabraDrugs stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for KabraDrugs in short term and the sell signal is strong.

KabraDrugs Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for KabraDrugs in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of KabraDrugs is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 24.61 and KabraDrugs 524322 stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the KabraDrugs 524322 stock. Volume based technical analysis of KabraDrugs 524322 stock is negative.

KabraDrugs Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Kabra Drugs 524322

DMA (daily moving average) of Kabra Drugs 524322

DMA period	DMA value
5 day DMA	24.45
12 day DMA	25.3
20 day DMA	25.23
35 day DMA	26.1
50 day DMA	26.61
100 day DMA	28.35
150 day DMA	26.96
200 day DMA	24.96

EMA (exponential moving average) of Kabra Drugs 524322

EMA period	EMA current	EMA prev	EMA prev2
5 day EMA	24.47	24.7	25.04
12 day EMA	24.96	25.13	25.33
20 day EMA	25.37	25.51	25.67
35 day EMA	26.03	26.15	26.27
50 day EMA	26.73	26.84	26.95

SMA (simple moving average) of Kabra Drugs 524322

SMA period	SMA current	SMA prev	SMA prev2
5 day SMA	24.45	24.64	24.8
12 day SMA	25.3	25.48	25.52
20 day SMA	25.23	25.29	25.42
35 day SMA	26.1	26.12	26.17
50 day SMA	26.61	26.74	26.88
100 day SMA	28.35	28.4	28.44
150 day SMA	26.96	26.93	26.89
200 day SMA	24.96	24.94	24.92

Fundamentals, profit and EPS of Kabra Drugs 524322

EPS is -0.46 and PE is: -52.2

Last quarter profit: (June 2022 quarter) -0.07 crores (-16.67%)

Debt: 1.03 in crores

Market capitalization: 2.07

EPS is -0.46 and PE is: -52.2

Last quarter profit: (June 2021 quarter) -0.06 crores (-50.00%)

Debt: 0.90 in crores

Market capitalization: 2.30

Videos related to: KabraDrugs 524322 full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI